UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

An Update on the Screening, Diagnosis, Management, and Treatment of Vitamin D Deficiency in Individuals with Cystic Fibrosis: Evidence-Based Recommendations from the Cystic Fibrosis Foundation

The journal of clinical endocrinology and metabolism, 2012-04, Vol.97 (4), p.1082-1093

2012

Volltextzugriff (PDF)

Beyond the expected: Identifying broad research priorities of researchers and the cystic fibrosis community

Journal of cystic fibrosis, 2019-05, Vol.18 (3), p.375-377

2019

Volltextzugriff (PDF)

Urinary metabolomics reveals unique metabolic signatures in infants with cystic fibrosis

Journal of cystic fibrosis, 2019-07, Vol.18 (4), p.507-515

2019

Volltextzugriff (PDF)

Effect of Aerosolized Recombinant Human DNase on Exacerbations of Respiratory Symptoms and on Pulmonary Function in Patients with Cystic Fibrosis

The New England journal of medicine, 1994-09, Vol.331 (10), p.637-642

1994

Volltextzugriff (PDF)

The cystic fibrosis intestine

Cold Spring Harbor perspectives in medicine, 2013-09, Vol.3 (9), p.a009753-a009753

2013

Volltextzugriff (PDF)

607 Evidence of protease dose-response in a Phase 1 trial of ANG003, a non-porcine pancreatic enzyme replacement therapy

Journal of cystic fibrosis, 2024-09, Vol.23, p.S336-S336

2024

Volltextzugriff (PDF)

671 Evidence of amylase dose-response in a Phase 1 trial of ANG003, a non-porcine pancreatic enzyme replacement therapy

Journal of cystic fibrosis, 2024-09, Vol.23, p.S376-S376

2024

Volltextzugriff (PDF)

606 Evidence of lipase dose-response in a Phase 1 trial of ANG003, a non-porcine pancreatic enzyme replacement therapy

Journal of cystic fibrosis, 2024-09, Vol.23, p.S335-S336

2024

Volltextzugriff (PDF)

614 Safety of ANG003, a non-porcine pancreatic enzyme replacement therapy in a Phase 1 study

Journal of cystic fibrosis, 2024-09, Vol.23, p.S341-S341

2024

Volltextzugriff (PDF)

Outcomes of infants with indeterminate diagnosis detected by cystic fibrosis newborn screening

Pediatrics (Evanston), 2015-06, Vol.135 (6), p.e1386-e1392

2015

Volltextzugriff (PDF)

WS6.3 Measures of nutritional status in two Phase 3 trials of ivacaftor in subjects with cystic fibrosis who have the G551D-CFTR mutation

Journal of cystic fibrosis, 2012-06, Vol.11, p.S13-S13

2012

Volltextzugriff (PDF)

Effects of Diagnosis by Newborn Screening for Cystic Fibrosis on Weight and Length in the First Year of Life

JAMA pediatrics, 2017-06, Vol.171 (6), p.546

2017

Volltextzugriff (PDF)

WS04.02 A novel test that identifies pancreatic enzyme replacement therapy dose-response based on breakdown of omega-3 fatty acids

Journal of cystic fibrosis, 2024-06, Vol.23, p.S7-S7

2024

Volltextzugriff (PDF)

High-Dose Pancreatic-Enzyme Supplements and Fibrosing Colonopathy in Children with Cystic Fibrosis

The New England journal of medicine, 1997-05, Vol.336 (18), p.1283-1289

1997

Volltextzugriff (PDF)

523 Phase 1 study of SNSP-003—a non-porcine pancreatic enzyme replacement therapy—using a novel endpoint

Journal of cystic fibrosis, 2023-10, Vol.22, p.S276-S277

2023

Volltextzugriff (PDF)

Diagnosis, screening and management of cystic fibrosis related diabetes mellitus: A consensus conference report

Diabetes research and clinical practice, 1999-08, Vol.45 (1), p.61-73

1999

Volltextzugriff (PDF)

Reproducibility of coefficient of fat absorption (CFA) in cystic fibrosis patients with pancreatic insufficiency

Journal of cystic fibrosis, 2010, Vol.9, p.S77-S77

2010

Volltextzugriff (PDF)

Evaluation of growth in peri-pubertal cystic fibrosis (CF) subjects with exocrine pancreatic insufficiency (EPI) treated with the novel non-porcine pancreatic enzyme replacement therapy liprotamase

Journal of cystic fibrosis, 2010, Vol.9, p.S87-S87

2010

Volltextzugriff (PDF)

206 Investigating colonic pH in cystic fibrosis: Wireless motility capsule to single-cell sequencing

Journal of cystic fibrosis, 2022-10, Vol.21, p.S122-S122

2022

Volltextzugriff (PDF)

Update on the evaluation of pancreatic exocrine status in cystic fibrosis

Current opinion in pulmonary medicine, 2005-11, Vol.11 (6), p.524-527

Borowitz, Drucy

2005

Volltextzugriff (PDF)

Genetic modifiers of liver disease in cystic fibrosis

JAMA : the journal of the American Medical Association, 2009-09, Vol.302 (10), p.1076

2009

Volltextzugriff (PDF)

Use of pancreatic enzyme supplements for patients with cystic fibrosis in the context of fibrosing colonopathy

The Journal of pediatrics, 1995-11, Vol.127 (5), p.681-684

1995

Volltextzugriff (PDF)

Denufosol Tetrasodium in Patients with Cystic Fibrosis and Normal to Mildly Impaired Lung Function

American journal of respiratory and critical care medicine, 2011-03, Vol.183 (5), p.627-634

2011

Volltextzugriff (PDF)

Intermittent Administration of Inhaled Tobramycin in Patients with Cystic Fibrosis

The New England journal of medicine, 1999-01, Vol.340 (1), p.23-30

1999

Volltextzugriff (PDF)

Use of fecal elastase-1 to classify pancreatic status in patients with cystic fibrosis

The Journal of pediatrics, 2004-09, Vol.145 (3), p.322-326

2004

Volltextzugriff (PDF)

1 – 25 von 374

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(324)
Mit Volltextzugriff
(323)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(218)
Humans
(205)
Life Sciences & Biomedicine
(201)
Biological And Medical Sciences
(136)
Medical Sciences
(134)
Male
(120)
Female
(111)
Child
(107)
Adolescent
(77)
Child, Preschool
(67)
Adult
(61)
Hematologic And Hematopoietic Diseases
(59)
Pediatrics
(59)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(56)
Hematology
(54)
Infant
(54)
Oncology
(42)
Prognosis
(34)
Treatment Outcome
(34)
Cystic Fibrosis
(31)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

An Update on the Screening, Diagnosis, Management, and Treatment of Vitamin D Deficiency in Individuals with Cystic Fibrosis: Evidence-Based Recommendations from the Cystic Fibrosis Foundation

Beyond the expected: Identifying broad research priorities of researchers and the cystic fibrosis community

Urinary metabolomics reveals unique metabolic signatures in infants with cystic fibrosis

Effect of Aerosolized Recombinant Human DNase on Exacerbations of Respiratory Symptoms and on Pulmonary Function in Patients with Cystic Fibrosis

The cystic fibrosis intestine

607 Evidence of protease dose-response in a Phase 1 trial of ANG003, a non-porcine pancreatic enzyme replacement therapy

671 Evidence of amylase dose-response in a Phase 1 trial of ANG003, a non-porcine pancreatic enzyme replacement therapy

606 Evidence of lipase dose-response in a Phase 1 trial of ANG003, a non-porcine pancreatic enzyme replacement therapy

614 Safety of ANG003, a non-porcine pancreatic enzyme replacement therapy in a Phase 1 study

Outcomes of infants with indeterminate diagnosis detected by cystic fibrosis newborn screening

WS6.3 Measures of nutritional status in two Phase 3 trials of ivacaftor in subjects with cystic fibrosis who have the G551D-CFTR mutation

Effects of Diagnosis by Newborn Screening for Cystic Fibrosis on Weight and Length in the First Year of Life

WS04.02 A novel test that identifies pancreatic enzyme replacement therapy dose-response based on breakdown of omega-3 fatty acids

High-Dose Pancreatic-Enzyme Supplements and Fibrosing Colonopathy in Children with Cystic Fibrosis

523 Phase 1 study of SNSP-003—a non-porcine pancreatic enzyme replacement therapy—using a novel endpoint

Diagnosis, screening and management of cystic fibrosis related diabetes mellitus: A consensus conference report

Reproducibility of coefficient of fat absorption (CFA) in cystic fibrosis patients with pancreatic insufficiency

Evaluation of growth in peri-pubertal cystic fibrosis (CF) subjects with exocrine pancreatic insufficiency (EPI) treated with the novel non-porcine pancreatic enzyme replacement therapy liprotamase

206 Investigating colonic pH in cystic fibrosis: Wireless motility capsule to single-cell sequencing

Update on the evaluation of pancreatic exocrine status in cystic fibrosis

Genetic modifiers of liver disease in cystic fibrosis

Use of pancreatic enzyme supplements for patients with cystic fibrosis in the context of fibrosing colonopathy

Denufosol Tetrasodium in Patients with Cystic Fibrosis and Normal to Mildly Impaired Lung Function

Intermittent Administration of Inhaled Tobramycin in Patients with Cystic Fibrosis

Use of fecal elastase-1 to classify pancreatic status in patients with cystic fibrosis

Suchergebnisse filtern